Stem Cell Authority, Ltd.
SCAL
$0.0045
-$0.0051-53.13%
06/30/2003 | 03/31/2003 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 0.00% | -1.90% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 0.00% | -1.90% | |||
Operating Income | 0.00% | 1.90% | |||
Income Before Tax | 0.00% | 2.80% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | 0.00% | 2.80% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 0.00% | 2.80% | |||
EBIT | 0.00% | 1.90% | |||
EBITDA | -- | -- | |||
EPS Basic | 0.00% | 2.78% | |||
Normalized Basic EPS | 0.00% | 0.00% | |||
EPS Diluted | 0.00% | 2.78% | |||
Normalized Diluted EPS | 0.00% | 0.00% | |||
Average Basic Shares Outstanding | 0.00% | 0.00% | |||
Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |